DE1667883A1 - Pharmazeutische Massen - Google Patents

Pharmazeutische Massen

Info

Publication number
DE1667883A1
DE1667883A1 DE19681667883 DE1667883A DE1667883A1 DE 1667883 A1 DE1667883 A1 DE 1667883A1 DE 19681667883 DE19681667883 DE 19681667883 DE 1667883 A DE1667883 A DE 1667883A DE 1667883 A1 DE1667883 A1 DE 1667883A1
Authority
DE
Germany
Prior art keywords
propanol
radical
parts
acid addition
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681667883
Other languages
German (de)
English (en)
Inventor
Smith Leslie Harold
Ralph Howe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE1667883A1 publication Critical patent/DE1667883A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19681667883 1967-02-27 1968-02-23 Pharmazeutische Massen Pending DE1667883A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61899467A 1967-02-27 1967-02-27
GB3855767 1967-08-22

Publications (1)

Publication Number Publication Date
DE1667883A1 true DE1667883A1 (de) 1971-08-12

Family

ID=26263851

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681667883 Pending DE1667883A1 (de) 1967-02-27 1968-02-23 Pharmazeutische Massen

Country Status (6)

Country Link
BE (1) BE711349A (cs)
CA (1) CA922629A (cs)
DE (1) DE1667883A1 (cs)
FR (1) FR8026M (cs)
IE (1) IE31952B1 (cs)
NL (1) NL6802588A (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085514A3 (en) * 1982-01-28 1984-02-29 Beecham Group Plc Compositions comprising a beta-antagonist and a beta-agonist, their preparation, and their use in treating obese humans and animals

Also Published As

Publication number Publication date
IE31952L (en) 1968-08-27
NL6802588A (cs) 1968-08-28
BE711349A (cs) 1968-08-27
CA922629A (en) 1973-03-13
IE31952B1 (en) 1973-02-21
FR8026M (cs) 1970-08-03

Similar Documents

Publication Publication Date Title
DE1792711C3 (de) Verwendung von Alkanolaminderivaten
DE2813480C2 (de) Arzneimittel-Depotpräparat vom Mehrfacheinheitsdosen-Typ
DE68922033T2 (de) Verwendung von Polyprenolen und Polyprenyl-Phosphaten zur Hemmung der Tumorzellen-Metastase.
DE69615984T2 (de) Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen
EP0529500B1 (de) Arzneimittel zur Behandlung von Abstossungsreaktionen bei Organverpflanzungen
DE69121551T2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
DE2206570A1 (de) Heilmittel zur Behandlung von Leber affektionen
DE1667883A1 (de) Pharmazeutische Massen
DE3311922A1 (de) Antifibrotische mittel
DE2323906A1 (de) Pharmazeutisches praeparat gegen fettleibigkeit
JP3515140B2 (ja) ブロイラー用腹水症防止剤及び腹水症防止方法
DE69626301T2 (de) Verwendung von allylaminderivaten wie terbinafin zur herstellung eines medikaments zur behandlung von mit einer helicobacter pylori infektion zusammenhängenden erkrankungen
EP0524512B1 (de) Antihypertensive Kombination
DE2631524C2 (cs)
DE3500756A1 (de) Verwendung von chinolonen zur behandlung der herzinsuffizienz
US4123553A (en) Anthelmintics effective against liver flukes
DE2504596A1 (de) Chemische verbindung und deren anwendung zur behandlung von haustieren
DE1963223A1 (de) Mittel zur Behandlung von Virusinfektionen
AT394946B (de) Verfahren zur behandlung von an primaer durch treponema hyodysenteriae verursachter schweinedysenterie leidenden schweinen
DE60122701T2 (de) Kosmetische oder dermatologische cremezubereitung, deren herstellung und verwendung
DE2855306A1 (de) Mittel zur senkung der herzfrequenz
DE68904050T2 (de) Methode zur kontrolle von pneumocystis carinii.
DE2314387B2 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
DE60311888T2 (de) Verwendung von hydroxamsäurederivaten zur herstellung von antitumorarzneimitteln
DE1793384A1 (de) 1-Amino-adamantanderivate